Bernard-Soulier syndrome (B&) is a rare congenital bleeding disorder caused by abnormal giant platelets. thrombocytopenia, and defective glycoprotein (GP) Ib-V-IX, the adhesion receptor for von Willebrand factor (vWF). This report describes the molecular defect in two related individuals with well-established B-Ss whose platelets exhibit decreased GPb-IX and normal GPV on their surfaces. The GPlb-V-IX genes of the two patients were analyzed by Southern blotting, hetero-duplex analysis, and polymerase chain reaction (PCR) ampliiication/sequencing. A point mutation was found in codon 129 of the GPlba gene that results in the substitution of proline for leucine in the first position of the fifth leucine-rich glycoprotein repeat of the mature gene product. The mutation (C=: leucine, wild-type t o CU2pro-line, mutant) eliminates a Sac I restriction site, facilitating analysis of the mutation in the propositi (both homozygotes), unaffected family members (8 heterozygotes and 8 wild-type), and 58 normal controls (116 wild-type alleles). The status of the genomes was confirmed by the sequencing ERNARD-SOULIER syndrome (B-Ss) is a rare congenital disorder of platelets first described by Drs Bernard and Soulier in Paris in 1948.' The syndrome is inherited in an autosomal recessive manner and is marked by giant circulating platelets, thrombocytopenia, and defective platelet adhesion? The associated bleeding diatheses range from mild to severe, and some rare B-Ss patients have suffered fatal hemorrhage.'~2 The molecular defect alters platelet glycoprotein (GP) Ib-V-IX, the surface receptor for von Willebrand factor (vWF) that mediates both platelet agglutination in response to ristocetin and platelet adhesion under conditions of rapid blood f l o~.~-~ Three proteins comprise the GPIb-V-M receptor. The dominant component is the GPIb heterodimer6 that consists of a larger vWF-binding chain, GPIba (molecular weight [Mr] 143 D), and a smaller phosphorylated chain, GPIbP (Mr 22 m).' GPIb is noncovalently associated with GPV (Mr 83 kD) and GPIX (Mr 20 kD).9"L In addition to the physical association noted above, the four distinct polypeptide~""~ all possess a least one leucine-rich glycoprotein (LRG) segment, a 24-amino acid sequence that distinguishes a large family of related protein^.^.'^.'^ The LRG region of GPIba is related to but may be separate from its vWF binding d~m a i n . '~~'~ The four Ib-V-IX genes share a common intron-depleted structure but lie in different chromosomal locations, ie, GPIba-17pl2-ter, Ibp-22q11.2, V-3q29, and IX-3q21 .20-25a Several molecular genetic defects in either the GPIba gene or the GPIX gene have been described in reported B-Ss kindred^.'^"' All of the receptor elements are affected in B-Ss to varying degrees?'0.26 implying that the members of the receptor associate with each other before surface expression can proceed. Consistent with these observations, data from transfection experiments show that at least three of the chains (h, Ibp, and IX) are needed for efficient surface expression of GPIba! with its binding site for vWF, We have investigated in this study two first cousins with severe B-Ss whose platelets have been the subject of earlier work by other investigators on GP Ib-V-IX, ie, observations concerning the role of the receptor in platelet adhesion and ristocetin-dependent agglutination: protein phosphorylation events due to c-AMP-dependent kinase,' the binding of thrombin to platelets:' the expression of platelet surface antigens,36 the generation of platelet coagulant a~tivity:~ and platelet membrane pla~ticity.~" We report that a point mutation in the GPIba gene, causing a 129leucine + proline substitution in the fifth LRG repeat of GPIba, appears to be responsible for the phenotype of these patients. The findings suggest that the leucine-rich motif of GPIba is a critically important element in GPIb-V-IX that can influence surface expression of the receptor and that may affect the binding of ligand to the receptor.
Hetero-Duplex Analysis
After the final PCR cycle, 5 mmol/L EDTA was added, and products from different PCR reactions were mixed, heated ( 3 minutes at 95"C), and cooled (30°C). Gel loading buffer was added, and hybrids were separated by electrophoresis (16 to 25 hours at approximately 800 V) in l-mm Hydrolink-MDE gel (AT Biochem, Inc, Malvern, PA) as de~cribed.4',~' Products were stained with 1 p@mL ethidium bromide and photographed under UV light.
Nucleotide Sequencing
PCR fragments were subcloned into the pCRII vector (Invitrogen, San Diego, CA) or M13 (GIBCO-BRL, Gaithersburg, MD). Plasmid DNA was prepared by adding 0.2 moVL NaOW2 mmoVL EDTA and incubating the mixture for 15 minutes at 3TC, whereas M13 was sequenced directly. The dideoxy chain termination method was used (Sequenase 2.0; US Biochemical [USB], Cleveland, OH)M with primers complementary to either the vector or the insert. The annealing temperature and MgC12 concentration refer to the pair made up of the primer in the same row and the one noted just above, except for the t footnote below: lba-9 and -11.
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* Primers GPlba-l and -2 were numbered with the transcriptional start site denoted as +l,19.20 whereas all the other GPlba primers (3 through 15) were numbered according to Rajagopalan and Konkle?' t Primer GPlbcr-9 was used with two antisense primers, GPlba-l0 and -1 1. The conditions for primer pair GPlba-9 and GPlba-l1 were annealing temperature of 62°C and 1.5 mmol/L MgC12. 
* Primers

Allele-Specijic Restriction Endonuclease Analysis
AGGTGGTCAAA), GPV (ACTCTACTGTGCGCGGTGCGG-
PCR products (20 pL) were incubated with restriction endonuclease following the manufacturer's instructions. The products of digestion were analyzed by electro-phoresis using 4% NuSieve agarose gel (FMC, Rockland, ME).
Assessment of Platelet Surface Antigens
Platelet-rich plasma (PRP) from normal individuals and clinically unaffected relatives was prepared from whole blood by centrifugation (300g for 5 minutes at 22°C). whereas PRP from the B-Ss patients was obtained by centrifugation at reduced speed (1508 for 4 minutes at 22°C). Platelets from the two homozygotes (111-3 and 111-5). one heterozygote (11-8). one related normal (Il-2), and two normal unrelated individuals were analyzed for surface antigen expression using a modification of a previously published method!' PRP was incubated (50 pW20 pL antibody for 15 minutes at 22°C) with mouse lgGl monoclonal antibodies recognizing platelet GPIb (anti-GPIb, CD42b-fluorescein isothiocyanate [FITC] ; inhibits ristocetin agglutination; Gen Trak, Plymouth Meeting, PA), GPIX (anti-GPIX, CD42a-FITC; Becton Dickinson, Mountain View, CA), GPV (anti-GPV. CD42d-FITC; CLB, Research Diagnostics, Inc. Flanders, NJ)," and GPIIIa (anti-GPIIIa, CD61-FITC; unreactive with platelets lacking GPIlb-IIIa; Becton Dickinson). Mouse IgGI-FITC was used as a control. Mouse IgGl fractions were FITC-labeled to similar extents. Platelet membrane expression of the antigens was determined by flow cytometry (FACScan; Becton Dickinson) and expressed as arbitrary mean peak channel fluorescence units, which were normalized to the signal generated with the anti-GPIIla monoclonal antibody, which was denoted as 100%.
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Binding of vWF to B-Ss Platelets vWF was purified from cyroprecipitate as described.& The purified protein in 100 mmol/L NaFQ, pH 6.5 (100 pL, 1 mg/mL) was labeled with I mCi of 1251 using two lodobeads (Pierce, Rockford, IL), and the radiolabeled protein was isolated by chromatography on PD-IO Sephadex G-25M (Pharma~ia).~"
Starting with 35 mL of whole blood, platelets were separated from the PRP of normal individuals and a B-Ss patient (111-5) by centrifugation (150g for I O minutes at 22°C). suspended in 35 mL of wash buffer (10 mmol/L Tris-Cl, pH 7.0, 0.14 m o m NaCI. 1 mmoliL EDTA), centrifuged (1 00g for 2 minutes at 22°C) to remove red blood cells (RBCs) and WBCs, and recentrifuged (1,OOOg for 10 minutes at 22°C) to provide a platelet pellet that was then resuspended in 1 mL of wash buffer.
Platelets (5 X IO6, 50 pL) were incubated with increased concentrations of '2sI-labeled vWF (1.4 to 70 pg/mL 12'I-vWF, 0.1 mL) in the presence (1.5 mg1mL) or absence of ristocetin and the presence (400 pg/mL) or absence of cold vWF. After incubation (30 minutes at 22°C). reactions were layered over 40 pL of silicone oil solution consisting of 80% Dow Coming 550 fluid (Dow Coming Corp. Midland, MI) and 20% 200 fluid (Nye Inc. New Bedford, MA). After centrifugation (10,OOOg for 2 minutes at 22°C). the supernatant was removed. the tube was inverted, and the pellet was clipped and assayed for radioactivity. The parallel incubations in the absence of ristocetin were performed to assess nonspecific binding.
Surface GPIha Expression in Transfected Cells
Plasmid construct. The entire open reading frame (2 kb) of wildtype and mutant GPIba genes was amplified with primer pair GPIba-5 , and GPlba-I5 ( taining 10% fetal bovine serum (FBS; GIBCO), 2 mmol/L L-glutamine, 1 0 0 U/mL penicillin, 0.1 mg/mL streptomycin (Sigma, St Louis, MO), 2.5 pg ImL amphotericin, 2.05 pg/mL sodium deoxycholate (GIBCO), 400 pgImL G41 8 (GIBCO), and SO pgImL methotrexate (MTX; Sigma). Transient fransfecfion. DNAniposome complexes prepared by gently combining the construct (10 pg) with DOTAP (50 pL; Boehringer Mannheim, Indianapolis, IN) in buffer (2.50 pL; 20 mmol/L HEPES, pH 7.4, 0.15 molL NaCI) and incubating for 10 minutes at 22°C were introduced into cells (1Oh/l00-mm dish; DMEM/2% FBS) over S hours (37"C, S% COz). Media was then changed to DMEM (10% FBS. 400 &mL (3418, and 50 pg ImL MTX), and cells were grown for 48 hours. Transfection efficiency was determined by cotransfection of an SV-40-luciferase reporter gene construct, pGL2 (2 pgldish),'" and luciferase activity was measured by mixing a cell lysate (20 pL) with luciferase assay reagent ( 1 0 0 pL; Promega) and assaying luciferase activity in a luminometer (Turner Designs, Inc. Mountain View, CA). To prepare the lysate, cells were harvested with EDTA, washed twice in phosphate-buffered saline (PBS). incubated with IX lysis buffer (400 pL; 100 mmol/L KZHP04, pH 7.8.6 mmol/L MgS04, 1 mmol/L dithiothreitol [Dm], 0.1 % Triton-I 0 0 ; IO minutes at 22"C), and clarified by centrifugation.
Flow cyfornerry. Surface expression of GPIbcv was evaluated by flow cytometry using a described, affinity-purified, rabbit polyclonal antibody specific for human glycocalicin/GPIba!' Cells were harvested with EDTA 48 hours after transfection, washed twice in PBS, and incubated with rabbit antihuman platelet glycocalicin polyclonal antibody (10 Becton Dickinson). The same antibody and detection method was also applied to mutant and wild-type platelets.
RESULTS AND DISCUSSION
Ident$cation of the Candidate Mutation in the Two Propositi
Southern blotting. To initiate the investigation of the molecular genetic defect in the two propositi, the genes of interest (GPIba, GPIbP, GPV, and GPIX) were analyzed by means of Southern blotting using specific, labeled cDNA or PCR probes for each gene. A11 of the blots showed normalsized fragments from all of the genes by single and double digestions with four different enzymes (EcoRI, HindIII, BarnHI, and Xho I). The analysis of the GPIba gene is shown in Fig 1, whereas the data for the GPIbP, GPV, and GPIX genes are not shown. The results suggest that gross deletions or rearrangements of the genes were not present and that such abnormalities did not constitute the genetic defect in the patients.
Hetero-duplex analysis.
Screening for more subtle defects, such as point mutations, was performed using the hetero-duplex analysis. The technique was applied to all of the genes except those encoding GPV, based on the assumption that defects in GPV may not produce a severe bleeding diathesis, because transfected cells can express significant amounts of surface Ib-IX complex in the absence of GPV." Using a series of primers (Table l) , all of the amplified segments from the three genes (Iba, IbP, and IX) in the two propositi (111-3 and 111-5) were found to be identical to normal using hetero-duplex analysis except for that produced by the GPIXJ and GPIX-6 primers (nucleotides 622 to 1256; Table 1 ). This fragment was subcloned into the pCRII vector, and a single base substitution at codon 27 (ACG + ACA) of the GPIX gene, a silent polymorphism, was found by sequencing. Patients 111-3 and 111-5 proved to be heterozy- gous and homozygous, respectively, for this polymorphism. Therefore, hetero-duplex analysis showed an apparant silent polymorphism but did not detect a mutation in the genes under study.
PCR amplijcation and sequencing of gene and cDNA segments. To study the genetic defect in this kindred further, the GPIba, GPIbP, and GPIX (including promoter re-3809 gions of GPIba and GPIX) genes of the patients were amplified in overlapping segments by PCR, and the products were analyzed on 2% agarose gels, which showed normal mobility and confirmed the absence of any major deletions. Sequencing of the genes was performed after subcloning the PCR fragments into the pCRII vector. A "T" "C" transition was found at codon 129 in GPIba gene (Fig 2) . A total of 20 different clones from 111-3 (12 clones) and 111-5 (8 clones) all contained the same mutation. Furthermore, with respect to the previously described normal polymorphic variation of a 13 amino acid sequence within the heavily glycosylated macroglycopeptide region of GPIba, the two propositi (III-3 and 111-5) were found to be homozygous for the twosegment, duplicated form (form C)."' Additional sequencing of platelet cDNA obtained by RT-PCR confirmed the CTC + CCC transition in codon 129 in both propositi (data not shown).
Distribution of the Mutant Allele in the B-Ss Kindred
Strategy of PCR amplijication and restriction endonuclease digestion. A Sac I restriction endonuclease cleavage site is lost because of the mutation, and a Sac I allele-specific restriction analysis (Sac I A-SRA) was performed to determine the distribution of the mutation in the kindred ( Fig  3A) . A 450-bp DNA fragment was amplified from the two propositi (111-3 and 111-5), available family members, and 58 normal controls (22 of them African-American) with the GPIba-7 and GPIba-8 primer pair ( Table 1) .
Results with samples from dgfferent individuals. Digestion of the 450-bp DNA fragments derived from normal controls yielded the expected 241-, 107-, and 102-bp fragments (lane 8, Fig 3B) . However, digestion of the products of the two propositi (111-3 and 111-5) produced only 241-and 209-bp fragments (lanes 2 and 4, Fig 3B) . The daughter (IV-1) of one propositus (111-5) was found to be heterozygous for the mutation (lane 6, Fig 3B) , along with 7 other family members. Sequencing of platelet cDNA from the mothers (11-3 and 11-4) of the propositi indicated heterozygosity for the mutation. The mutation was absent in 8 members of the kindred and in all 58 normal controls (1 16 normal alleles). The results confirm that both propositi are homozygous for the mutation and are consistent with autosomal recessive inheritance of the mutant allele in the kindred (Fig 4) . The results with the normal individuals indicate that the mutation does not appear to be a polymorphism (defined as present in 1% or more of normals).
Site of the mutation within GPIba. The point mutation in codon 129 of the mature gene product results in the substitution of proline ( P mutant) for leucine (L: wild-type) as the first amino acid of the fifth leucine-rich repeat of the GPIba polypeptide (Fig 5) .
The Effect of the Point Mutation on GPIba Expression and Function
Assessment of GPIb-V-IX antigens on the platelet s u~a c e .
Because diminished surface GPIb-V-IX is a hallmark of B- ? ?
A IV-l Fig 6, the GPIb-IX surface antigens were present at a level approximately 25% to 40% of normal in both propositi as compared with both normal platelets and those from heterozygous family members. The extent of expression was determined by correcting data by means of the ratio of GPIb-IX and GPIIb-IIIa on normal platelets. However, as seen in another B-Ss kindred,l' surface GPV was found in essentially normal amounts (93%) in the platelets of the propositi, suggesting that GPV can be expressed in a differential fashion with its expression maintained to a greater extent than that of the other members of the GPIb-V-IX system. Analysis of total GPIb-IX antigen by Western blotting using polyclonal antibodies indicated increased amounts (presumeably intracellular) of GPIba, IbP, and IX in the homozygous mutant platelets. Analysis of platelet RNA by Northern blotting showed increased amounts, by approximately one third, of GPIbaIP and IX mRNA in samples from the propositi as compared with normal samples (data not shown). Quantitative PCR showed approximately normal amounts of these same transcripts in the platelets from the two affected individuals (Fig 7) . Therefore, the point mutation in codon 129 does not appear to affect transcription of the genes under study but does selectively decrease surface expression of GPIb-IX, while sparing that of GPV. The substitution of proline for leucine may alter the conformation of the Ib-IX complex in some undefined fashion, perhaps related to the fact that a proline insertion disturbs the alignment of a polypeptide chain. As a consequence of the mutation and resultant amino acid substitution, synthesis, and/or cytoplasmic transport of platelet GPIba in the megakaryocyte appears to be affected, perhaps along with an effect on GPIbp and GPIX; and the amount of surface GPIb-IX complex on platelets is decreased.
The effect of the mutation on ristocetin-dependent vWF binding. Earlier studies document the complete inability of the propositi' platelets to agglutinate in response to ristoeti in,^ and we repeated the study with the same result (no ristocetin-induced agglutination; data not shown). The fact that mutant platelets possess 25% to 40% of the normal amount of surface receptor (Fig 6) makes the results with ristocetin somewhat unexpected, because one could theorize that the decreased amount of receptor might still mediate ristocetin-dependent agglutination to some extent, albeit a reduced extent. Earlier studies of the propositi report variable results in regard to the amount and activity of the surface GPIb-IX receptor of the mutant platelets. For example, about 35% of normal thrombin binding and factor X1 interaction was f o~n d ,~' .~' whereas platelet adhesion, drug-dependent antigen sites, collagen-induced coagulant activity, and GPIbP phosphorylation were reported as absent.s,K,36 To pursue this type of observation, we measured the extent of '"1-vWF binding to the mutant platelets of one of the propositi and found that the extent of ligand binding parallelled that of surface antigen expression (Fig 8) . When platelets were exposed to progressively increasing amounts of "'I-vWF in the presence of ristocetin, vWF binding was consistently BSs MW NL GP Ib a p actin Alternatively, the absence of ristocetin agglutination may simply reflect a reduced amount of functional receptor, and ristocetin agglutination may be a somewhat insensitive indicator of ligand binding, requiring some minimal amount of surface receptor to proceed. However, this formulation appears to be at odds with the clinical data in which the patients suffer from a severe bleeding diathesis stemming from a severe defect in in vivo platelet adhesion, presumably more severely deficient in vivo than 25% to 40% of normal. The results suggest, but do not prove, that an alteration of the polypeptide chain in the LRG region of Iba may selectively affect the chain's interaction with vWF (absent ristocetin agglutination, severely impaired vWF-dependent platelet adhesion, and apparently normal binding of soluble vWF in vitro). This influence may occur despite the fact that the LRG region (residues 36 to 200)12 is somewhat removed from the described linear vWF binding region of Iba (residues 235 to 279)I8,l9 and may or may not be part of the site itself.
Transfection of Mutant cDNA Into Ibp-IX Host Cells
To study further the effect of the mutation on the surface expression of the GPIba polypeptide, an in vitro transfection study was performed. Both wild-type and mutant GPIba cDNAs were transiently transfected into L cells that had been previously transformed with stable constructs expressing GPIbP and As shown in Fig 9, 43% of cells expressed GPIba protein on their surface when transfected with normal GPIba cDNA under the described conditions. However, no GPIba expression could be appreciated on the surface of the cells transfected with the mutant GPIba cDNA or with the antisense wild-type control. Both of the latter forms of transfected cells did not differ from an untransfected control, although when using slot blot analysis both of these transfected cell populations had the same content of Iba transcripts as did the cells transfected with the wild-type construct. The luciferase activity of the various samples was the same in all of the transfected cells, indicating that transfection efficiency did not differ for the different constructs. The same polyclonal antibody, when applied to platelets in separate experiments, detected 35% of control antigen levels on the homozygous mutant platelets. The results show that L cells transfected with wild-type GP Iba cDNA express GPIba protein on their surfaces, whereas those transfected LI, MARTIN, AND ROTH with the mutant cDNA do not. The finding is generally consistent with the results of the flow cytometric assay of platelet surface antigens. In both instances, the point mutation appears to depress the expression of the GPIba protein on the surface of the cells. The mutation in megakaryocytes leads to a 50% to 70% decrease in GPIba surface expression (observed on the platelet surface), but it nearly eliminates such expression in transfected p-IX L cells. The reason for this difference may relate to differences between the two cells, ie, megakaryocytes as opposed to L cells, in their relative abilities to express surface Ib-IX. Megakaryocytes appear to express both wild-type and mutant Ib-IX to a greater extent than do L cells, and megakaryocytes may process the altered protein more successfully, thereby expressing somewhat higher levels of the mutant receptor.
The Described Point Mutation in the LRG Domain of Iba
The described point mutation in GPIba affects surface expression of the Ib-IX complex in transfected cells in much the same manner as it appears to suppress expression of the receptor on the surface of mutant platelets. The transfection data, the finding of homozygosity for the mutant allele in the propositi, and the absence of the mutation in normals argue strongly that the described mutation is responsible for the B-Ss phenotype seen in the platelets of the affected patients. The effect of the mutation is striking. The single amino acid substitution does not influence gene transcription or intracellular protein levels, but it appears to alter the highly integrated nature of the multicomponent GPIb-IX complex. A significant decrease in the amount of surface GPIb-IX receptor results, but the reduced amount of receptor can bind vWF while failing to mediate ristocetin agglutination. The described change in the polypeptide chain of GPIba appears to lie outside of its vWF binding region, and the mutant receptor chain still binds the soluble vWF ligand while failing to produce subsequent ristocetin-dependent agglutination. Perhaps, the molecular conformation of ligand binding plays a critical role in subsequent cellular events such as agglutination. Therefore, a subtle alteration in the LRG region of GPIba can markedly disrupt surface expression of GPIb-IX and may selectively change the nature of receptor-ligand interaction. The results imply that the multicomponent GPIb-IX receptor is highly interdependent and that its expression and perhaps function can be affected by the change of a single amino acid in a single receptor chain.
